Week In Review: Suzhou’s Ascentage Pharma Stages $53 Million IPO In Hong Kong
Taiwan Liposome Company completed a $27.3 million secondary offering to advance its own nanomedicine candidates for pain control, ophthalmology and oncology. Milu Labs, a Philadelphia company focused on attracting diagnostics to China/Asia, signed an MOU with Thermo Fisher to create a noninvasive test that will evaluate the risk of adverse…
News story published on 2019-10-27T12:19:00.0000000Z
